A detailed history of Bragg Financial Advisors, Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Bragg Financial Advisors, Inc holds 3,606 shares of EW stock, worth $244,342. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,606
Previous 4,044 10.83%
Holding current value
$244,342
Previous $373,000 36.46%
% of portfolio
0.01%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$59.7 - $93.78 $26,148 - $41,075
-438 Reduced 10.83%
3,606 $237,000
Q4 2022

Feb 14, 2023

SELL
$68.3 - $87.44 $86,262 - $110,436
-1,263 Reduced 23.8%
4,044 $301,000
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $36,407 - $47,422
-442 Reduced 7.69%
5,307 $439,000
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $22,144 - $32,837
-256 Reduced 4.26%
5,749 $547,000
Q1 2022

May 11, 2022

BUY
$101.96 - $128.34 $1,325 - $1,668
13 Added 0.22%
6,005 $707,000
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $8,644 - $10,311
84 Added 1.42%
5,992 $678,000
Q2 2021

Aug 16, 2021

SELL
$83.84 - $104.76 $3,521 - $4,399
-42 Reduced 0.71%
5,908 $612,000
Q1 2021

May 14, 2021

SELL
$78.68 - $90.67 $34,383 - $39,622
-437 Reduced 6.84%
5,950 $498,000
Q4 2020

Feb 11, 2021

BUY
$71.69 - $91.23 $4,731 - $6,021
66 Added 1.04%
6,387 $583,000
Q3 2020

Nov 13, 2020

SELL
$67.19 - $87.44 $14,109 - $18,362
-210 Reduced 3.22%
6,321 $505,000
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $231,828 - $310,031
4,029 Added 161.03%
6,531 $451,000
Q4 2019

Feb 14, 2020

SELL
$71.7 - $82.09 $4,588 - $5,253
-64 Reduced 2.49%
2,502 $584,000
Q3 2018

Nov 14, 2018

BUY
$45.7 - $58.03 $1,690 - $2,147
37 Added 1.46%
2,566 $447,000
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $91,777 - $98,201
2,529
2,529 $276,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Bragg Financial Advisors, Inc Portfolio

Follow Bragg Financial Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bragg Financial Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bragg Financial Advisors, Inc with notifications on news.